Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.

Syed Shahzad MustafaKarthik VadamalaiBryan ScottAllison Ramsey

Published in: American journal of rhinology & allergy (2020)

Dupilumab was highly effective as add-on therapy for CRSwNP in AERD, improving patient-reported outcomes, sinus opacification, and markers of T2 inflammation.

Keyphrases

chronic rhinosinusitis
patient reported outcomes
atopic dermatitis
low dose
oxidative stress
cardiovascular events
antiplatelet therapy
cardiovascular disease
acute coronary syndrome
atrial fibrillation